Pages that link to "Q52003673"

The following pages link to Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. (Q52003673):

Displaying 19 items.

• Platelets and Alzheimer's disease: Potential of APP as a biomarker (Q27001550) (← links)
• What is the dominant Abeta species in human brain tissue? A review (Q28301724) (← links)
• Biomarkers of Alzheimer's disease: from central nervous system to periphery? (Q34442605) (← links)
• Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? (Q34500658) (← links)
• Discriminative and predictive power of an informant report in mild cognitive impairment (Q36142635) (← links)
• Advances on biological markers in early diagnosis of Alzheimer disease. (Q36192471) (← links)
• Alzheimer disease and platelets: how's that relevant (Q36535484) (← links)
• Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? (Q37118083) (← links)
• Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty (Q37297626) (← links)
• Biomarkers of Alzheimer's disease in body fluids (Q37769463) (← links)
• The development of effective biomarkers for Alzheimer's disease: a review (Q38016800) (← links)
• The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis (Q39450376) (← links)
• Platelet alpha- and beta-secretase activities: A preliminary study in normal human subjects (Q46145107) (← links)
• Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease (Q47718992) (← links)
• Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome (Q50307674) (← links)
• Conformationally altered p53: a novel Alzheimer's disease marker? (Q51900746) (← links)
• Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. (Q53267929) (← links)
• Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. (Q53328612) (← links)
• Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. (Q53371647) (← links)